• Product NameBTB06584
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityBTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB). BTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase.
• Target NameATPase inhibitor; RAAS inhibitor
• CAS No. 219793-45-0
• Calculated MW 417.82
• Formulation C19H12ClNO6S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:[O-][N+](=O)C1=C(OC(=O)C2=CC=C(Cl)C=C2)C=C(C=C1)S(=O)(=O)C1=CC=CC=C1
  Pathways:Endocrinology/Hormones; Membrane transporter/Ion channel
  Receptor:ATPase; Acetohydroxyacid synthase
  Boling pt:
  Melting pt:
  Solubility:DMSO: 84 mg/mL (201.04 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Wang D, et al. J Chem Inf Model. 2013 Feb 25;53(2):343-53.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting